Cil Laboratories Private Limited, a active private limited company, was established on 14 June 2016 in Kolkata, West Bengal, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U36999WB2016PTC216162. Registered under ROC Roc Kolkata. it is unlisted. It has an authorized capital of ₹4.00 Cr and a paid-up capital of ₹3.71 Cr.
It upholds a compliant status. Its leadership includes Santanu Bakshi (Director), Sharad Kumar Agarwal (Director), Siddharth Tibrewal (Director). Past directors included Rakesh Agarwal, Santanu Bakshi, Sharad Kumar Agarwal. It holds ₹1.00 Cr open charges and ₹6.00 M settled loans. Its latest AGM occurred on 28 September 2024, with the balance sheet filed on 31 March 2024. It is based at Agarwal House, 2Nd Georges Gate Road Hastings, 2Nd Floor, Kolkata, West Bengal, 700022.
U36999WB2016PTC216162
216162
14 June 2016
₹4.00 Cr
₹3.71 Cr
Roc Kolkata
Unlisted
Active
Explore comprehensive insights into Cil Laboratories Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Santanu Bakshi | Director | 20 Mar 2017 | Current |
| Sharad Kumar Agarwal | Director | 30 Mar 2023 | Current |
| Siddharth Tibrewal | Director | 09 Sep 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 20 Oct 2021 | Past |
| Pramod Abcsdd | Additional Director | 30 Dec 2017 | Past |
| Pramod Abcsdd | Director | 25 Mar 2017 | Past |
| Pramod Abcsdd | Director | 12 Mar 2021 | Past |
| Pramod Abcsdd | Additional Director | 20 Oct 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Cil Laboratories Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 26590.48% increase. The company also saw a substantial improvement in profitability, with a 123.31% increase in profit. The company's net worth moved up by a moderate rise of 2.77%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Cil Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹10,020,110.00
₹6,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 Jan 2025 | Indian Overseas Bank | ₹5.00 M | Open |
| 04 Nov 2022 | Indian Overseas Bank | ₹4.00 M | Open |
| 21 May 2022 | Others | ₹1.02 M | Open |
| 05 Jan 2019 | Others | ₹6.00 M | Satisfied |
Explore comprehensive loan charge details -
Cil Laboratories has a workforce of 0 employees as of Mar 27, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Cil Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cil Laboratories's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Indian Overseas Bank amounted to Rs. 0.50 Cr with Charge ID 101060871 was registered on 17 Jan 2025. was recorded as a recent event.
Cil Laboratories Private Limited last Annual general meeting of members was held on 28 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity Cil Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kolkata. was completed.
The activity A charge with Indian Overseas Bank of Rs. 0.40 Cr registered on 04 Nov 2022 with Charge ID 100643489 was modified on 25 Aug 2023. was completed.
The activity Sharad Kumar Agarwal was appointed as a Director was appointed as a Director on 30 Mar 2023 & has been associated with this company since 2 years 8 months . was completed.
The activity A charge registered on 05 Jan 2019 via Charge ID 100242276 with Others was fully satisfied on 10 Nov 2022. was completed.
The CIN of Cil Laboratories Private Limited is U36999WB2016PTC216162.
Cil Laboratories Private Limited is headquartered at Agarwal House, 2Nd Georges Gate Road Hastings, 2Nd Floor, Kolkata, West Bengal, 700022.
Cil Laboratories Private Limited was incorporated on 14 June 2016.
The current directors of Cil Laboratories Private Limited are
The primary industry of Cil Laboratories Private Limited is Manufacturing.
Cil Laboratories Private Limited is unlisted.
The authorized capital of Cil Laboratories Private Limited is ₹4.00 Cr, and the paid-up capital is ₹3.71 Cr.
The compliance status of Cil Laboratories Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX